TAO Is Tackling Problems Big Pharma Won’t Touch

TAO Is Tackling Problems Big Pharma Won’t Touch

The decentralized science (DeSci) sector just surged to a $930M market cap—but the real breakthrough isn’t just in token prices. It’s happening inside Bittensor’s specialized subnets, where researchers and builders are tackling problems most Big Tech companies avoid.

Unlike traditional pharma or AI labs that spend years navigating regulations, these decentralized AI networks are moving fast, experimenting openly, and in some cases already onboarding millions of users.

Here are four of the most disruptive DeSci-focused Bittensor subnets right now:

🧬 Metanova (SN68) – Virtual Drug Screening

  • Already considered the “most capital efficient” drug discovery platform in the ecosystem.
  • Currently targeting HDAC3/HDAC8 inhibitors for PTSD and Alzheimer’s—therapies that would take pharma giants 10+ years to develop.
  • By decentralizing the R&D, Metanova is pushing forward drug discovery without waiting for pre-approval greenlight.

🔬 Macrocosmos (SN25) – Protein Folding

  • Has folded +185,614 proteins all-time—a core challenge in computational biology.
  • Demonstrates real scientific progress, not just token speculation.
  • Features a real-time leaderboard so contributors can track miner impact on research.

🧠 BetterTherapy (SN102) – Mental Health AI Twin

  • Launched with validators achieving 100%+ performance.
  • Building AI twins for therapy, turning sessions into on-chain tokenized assets.
  • Provides anonymous, uncensorable mental health support—outside the reach of HIPAA or insurance gatekeepers.

🤖 Dippy (SN11) – AI Companions Without Censorship

  • Exploded to 8 million users in its first year.
  • Generates 1.5M monthly website visits, doubling traffic month-over-month.
  • Often described as the “OnlyFans of AI,” offering companionship and wellness services no centralized corporation would touch.

Why This Matters

  • Regulatory Arbitrage: These subnets thrive in spaces where corporations are restricted or unwilling to go.
  • Real Users: Dippy’s 8M users alone surpass the adoption of most Web3 protocols combined.
  • Revenue Models: BetterTherapy is literally tokenizing therapy sessions, showing a real economic use case.
  • Uncensorable Science: Metanova and Macrocosmos are advancing research without FDA pre-approval slowing things down.

While DeSci as a market is gaining attention, the real innovation is happening inside these Bittensor subnets—where open, incentive-aligned AI networks are tackling problems too complex, risky, or controversial for Big Tech.

Up next, stay tuned as we do a deep dive of each of these Bittensor subnets.

Subscribe to receive The Tao daily content in your inbox.

We don’t spam! Read our privacy policy for more info.

Be the first to comment

Leave a Reply

Your email address will not be published.


*